Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
AY.99 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.99 (Delta)NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
AY.120.2 (Delta)ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.322ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.322ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.322ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.322NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.160.23ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.160.23ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.160.23ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.160.23NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.416ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.416ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.416ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.416NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.239ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.239ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.239ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.239NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.375ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.375ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.375ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.375NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.432ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.432ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.432ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.432NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.241ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.241ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.241ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.241NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.298ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.298ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.298ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.298NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.433ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.433ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.433ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.433NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.39ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.39ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.39ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.39NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.561ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.561ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.561ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.561NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.605ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.605ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.605ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used